par  Michel, Charlotte  ;Martin, Charlotte
;Martin, Charlotte  ;Smeesters, Pierre
;Smeesters, Pierre  ;Goffard, Jean-Christophe
;Goffard, Jean-Christophe  ;Demuyser, Thomas;Hallin, Marie
;Demuyser, Thomas;Hallin, Marie 
Référence Frontiers in Medicine, 10, page (1225408)
Publication Publié, 2023-10-01
           ;Martin, Charlotte
;Martin, Charlotte  ;Smeesters, Pierre
;Smeesters, Pierre  ;Goffard, Jean-Christophe
;Goffard, Jean-Christophe  ;Demuyser, Thomas;Hallin, Marie
;Demuyser, Thomas;Hallin, Marie 
Référence Frontiers in Medicine, 10, page (1225408)
Publication Publié, 2023-10-01
                                                                                                       
			Article révisé par les pairs
                                                  
        | Résumé : | The translation of Next-Generation Sequencing (NGS) from research to clinical microbiology is increasing rapidly, but its integration into routine clinical care struggles to catch-up. A challenge for clinical laboratories is that the substantial investments made in the required technologies and resources must meet both current and forthcoming needs. | 



